by Charlie Helps FRSA | Jul 22, 2026 | Corporate Governance
Whilst 76% of corporate directors utilise artificial intelligence in their board activities, a mere 8% report having the expertise required to oversee it. You likely recognise that this expertise gap creates a vacuum where algorithmic reliance erodes institutional...
by Charlie Helps FRSA | Jul 21, 2026 | Corporate Governance
The Board remains the ultimate arbiter of clinical safety and institutional integrity. Whilst the allure of algorithmic efficiency is undeniable, many NHS leaders feel a justified trepidation regarding the opaque nature of automated decision-making. You likely...
by Charlie Helps FRSA | Jul 20, 2026 | Corporate Governance
Intentions are not assurance. A Board may harbour the most virtuous aspirations for patient safety; however, without the structural discipline to translate these desires into evidenced movement, they remain regulatory vulnerabilities. Achieving CQC compliance is not a...
by Charlie Helps FRSA | Jul 17, 2026 | Corporate Governance
Compliance is not a surrogate for care. Whilst the pursuit of NHS Quality and Safety often dissolves into a sequence of administrative rituals, true institutional fidelity requires a more rigorous architectural approach from the Board. You likely recognise the...
by Charlie Helps FRSA | Jul 16, 2026 | Corporate Governance
The most dangerous assumption a Non-Executive Director can make is that presence equals protection. True NED accountability is not a static designation; it is a continuous, evidenced movement through a credible plan to fulfil a specific mandate. You likely find...
